Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.

Edith A. Perez, Barry Lembersky, Paul Kaywin, Leonard Kalman, Karen Yocom, Carl Friedman

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalThe cancer journal from Scientific American
Volume4
StatePublished - Jan 1 1998

Disciplines

  • Anesthesiology
  • Medicine and Health Sciences

Cite this